Table 3.

The level and duration of fights (median, IQR and n) between losers matched against winners.

Losers vs. winners	Fight level median, IQR (n)			Fight duration, s median, IQR
	No AS	Male-AS	p-value	No AS	Male-AS	p-value
Vehicle	1, 1–1.75 (20)	5, 2.25–5 (20)	<0.001	0, 0–3	5, 3.25–9	<0.001
DAR-blocker	1, 1–1 (20)	3.5, 1–5 (20)	0.0033	0, 0–0.75	2.5, 0–6.75	0.0058
OAR-blocker	1, 1–2 (20)	1, 1–3 (22)	0.912	0, 0–1	0, 0–4	0.832
Vehicle	1, 1–2.5 (25)	4, 1–5 (23)	<0.001	0, 0–2	4, 0–8	<0.001
DAR-agonist	4, 3.25–5 (20)	3, 2–5 (20)	0.8354	3, 0–9.75	3, 1–5.75	0.97
OAR-agonist	2.5, 1–6 (20)	5, 4.75–6 (22)	0.023	7, 3.25–8.75	11, 6–39.25	0.04

The losers received either no antennal stimulation (no AS) or stimulation with a male antennae 5 min before fighting (male-AS). The crickets were treated with either: the DAR-blocker fluphenazine, the OAR-blocker epinastine, the DAR-agonist homovanillyl alcohol or the OAR-agonist chlordimeform, or vehicle (1% DMSO, separate controls for blockers and agonists). The p-values from U-tests comparing groups that received no AS and male-AS are given for each treatment (statistically significant values in bold face). The data are depicted in Figure 6.